Long Noncoding RNA Lnc-TLN2-4:1 Suppresses Gastric Cancer Metastasis and Is Associated with Patient Survival

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Gastric cancer (GC) is a prevalent malignancy globally, with metastasis significantly impacting patient prognosis.
• Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cancer progression, yet their specific functions in GC metastasis are not fully understood.

Purpose of the Study:

• To identify and characterize novel lncRNAs involved in gastric cancer metastasis.
• To elucidate the functional role and mechanism of the lncRNA lnc-TLN2-4:1 in GC progression.

Main Methods:

• Quantitative real-time PCR to assess lncRNA expression in GC tissues and cell lines.
• Cell migration and invasion assays (e.g., Transwell assays) to evaluate cellular motility.
• Western blotting and qRT-PCR to determine protein and mRNA expression levels of target genes.

Main Results:

• lnc-TLN2-4:1 expression was significantly decreased in GC tissues compared to normal tissues.
• Low lnc-TLN2-4:1 expression correlated with lymph node metastasis, distant metastasis, and reduced overall survival in GC patients.
• lnc-TLN2-4:1 suppressed GC cell migration and invasion without affecting proliferation, and it is primarily localized in the cytoplasm.
• lnc-TLN2-4:1 positively regulated the mRNA and protein expression of TLN2 in GC cells.

Conclusions:

• lnc-TLN2-4:1 functions as a tumor suppressor in gastric cancer by inhibiting cell migration and invasion.
• The downregulation of lnc-TLN2-4:1 is a potential biomarker for poor prognosis in GC patients.
• lnc-TLN2-4:1 may represent a novel therapeutic target for overcoming GC metastasis.